| Gina Grantham, DPT | |
|
6137 Tittabawassee Rd Ste 3, Saginaw, MI 48603-9696 | |
| (895) 580-9049 | |
| Not Available |
| Full Name | Gina Grantham |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 6137 Tittabawassee Rd Ste 3, Saginaw, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194329896 | NPI | - | NPPES |
| 5501019829 | Other | MI | STATE OF MICHIGAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 5501019829 (Michigan) | Secondary |
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Entity Name | Renue 003 Saginaw Llc |
|---|---|
| Entity Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Entity Identifiers | NPI Number: 1578845285 PECOS PAC ID: 4981870870 Enrollment ID: O20111227000057 |
News Archive
The death rates of individual heart surgeons have been published in England and several US states for some years. A high profile investigation into high death rates at a certain cardiac centre motivated this in England. For other surgery types, death rates have been reported only at the hospital or trust level. NHS England's "Everyone Counts" policy, introduced this Summer, means that outcomes of ten types of surgery will be reported at the individual surgeon level.
Tocagen Inc. today announced the publication of data showing the company's investigational treatment for high grade glioma eradicates brain tumors and provides a dramatic survival benefit in mouse models of glioblastoma.
The community of microorganisms that resides in the gut, known as the microbiome, has been shown to work in tandem with the genes of a host organism to regulate insulin secretion, a key variable in the onset of the metabolic disease diabetes.
An enzyme known for its role in heart disease may well be a promising target to treat asthma. Researchers from the University of Iowa have found that the enzyme, called CaMKII, is linked to the harmful effects of oxidation in the respiratory tract, triggering asthmatic symptoms.
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
› Verified 2 days ago
| Entity Name | Renue 001 Freeland Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922385707 PECOS PAC ID: 8325206535 Enrollment ID: O20120220000587 |
News Archive
The death rates of individual heart surgeons have been published in England and several US states for some years. A high profile investigation into high death rates at a certain cardiac centre motivated this in England. For other surgery types, death rates have been reported only at the hospital or trust level. NHS England's "Everyone Counts" policy, introduced this Summer, means that outcomes of ten types of surgery will be reported at the individual surgeon level.
Tocagen Inc. today announced the publication of data showing the company's investigational treatment for high grade glioma eradicates brain tumors and provides a dramatic survival benefit in mouse models of glioblastoma.
The community of microorganisms that resides in the gut, known as the microbiome, has been shown to work in tandem with the genes of a host organism to regulate insulin secretion, a key variable in the onset of the metabolic disease diabetes.
An enzyme known for its role in heart disease may well be a promising target to treat asthma. Researchers from the University of Iowa have found that the enzyme, called CaMKII, is linked to the harmful effects of oxidation in the respiratory tract, triggering asthmatic symptoms.
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
› Verified 2 days ago
| Entity Name | Renue 002 Bay City Llc |
|---|---|
| Entity Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Entity Identifiers | NPI Number: 1922379320 PECOS PAC ID: 3678735560 Enrollment ID: O20120511000056 |
News Archive
The death rates of individual heart surgeons have been published in England and several US states for some years. A high profile investigation into high death rates at a certain cardiac centre motivated this in England. For other surgery types, death rates have been reported only at the hospital or trust level. NHS England's "Everyone Counts" policy, introduced this Summer, means that outcomes of ten types of surgery will be reported at the individual surgeon level.
Tocagen Inc. today announced the publication of data showing the company's investigational treatment for high grade glioma eradicates brain tumors and provides a dramatic survival benefit in mouse models of glioblastoma.
The community of microorganisms that resides in the gut, known as the microbiome, has been shown to work in tandem with the genes of a host organism to regulate insulin secretion, a key variable in the onset of the metabolic disease diabetes.
An enzyme known for its role in heart disease may well be a promising target to treat asthma. Researchers from the University of Iowa have found that the enzyme, called CaMKII, is linked to the harmful effects of oxidation in the respiratory tract, triggering asthmatic symptoms.
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
› Verified 2 days ago
| Entity Name | Renue 006 Saginaw State St Llc |
|---|---|
| Entity Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Entity Identifiers | NPI Number: 1871835405 PECOS PAC ID: 4688817711 Enrollment ID: O20130821000483 |
News Archive
The death rates of individual heart surgeons have been published in England and several US states for some years. A high profile investigation into high death rates at a certain cardiac centre motivated this in England. For other surgery types, death rates have been reported only at the hospital or trust level. NHS England's "Everyone Counts" policy, introduced this Summer, means that outcomes of ten types of surgery will be reported at the individual surgeon level.
Tocagen Inc. today announced the publication of data showing the company's investigational treatment for high grade glioma eradicates brain tumors and provides a dramatic survival benefit in mouse models of glioblastoma.
The community of microorganisms that resides in the gut, known as the microbiome, has been shown to work in tandem with the genes of a host organism to regulate insulin secretion, a key variable in the onset of the metabolic disease diabetes.
An enzyme known for its role in heart disease may well be a promising target to treat asthma. Researchers from the University of Iowa have found that the enzyme, called CaMKII, is linked to the harmful effects of oxidation in the respiratory tract, triggering asthmatic symptoms.
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
› Verified 2 days ago
| Entity Name | Renue 009 Midland Llc |
|---|---|
| Entity Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Entity Identifiers | NPI Number: 1174963961 PECOS PAC ID: 1557596376 Enrollment ID: O20131104001170 |
News Archive
The death rates of individual heart surgeons have been published in England and several US states for some years. A high profile investigation into high death rates at a certain cardiac centre motivated this in England. For other surgery types, death rates have been reported only at the hospital or trust level. NHS England's "Everyone Counts" policy, introduced this Summer, means that outcomes of ten types of surgery will be reported at the individual surgeon level.
Tocagen Inc. today announced the publication of data showing the company's investigational treatment for high grade glioma eradicates brain tumors and provides a dramatic survival benefit in mouse models of glioblastoma.
The community of microorganisms that resides in the gut, known as the microbiome, has been shown to work in tandem with the genes of a host organism to regulate insulin secretion, a key variable in the onset of the metabolic disease diabetes.
An enzyme known for its role in heart disease may well be a promising target to treat asthma. Researchers from the University of Iowa have found that the enzyme, called CaMKII, is linked to the harmful effects of oxidation in the respiratory tract, triggering asthmatic symptoms.
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
› Verified 2 days ago
| Entity Name | Renue 004 Bridgeport Llc |
|---|---|
| Entity Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Entity Identifiers | NPI Number: 1952740466 PECOS PAC ID: 4183850266 Enrollment ID: O20131119001767 |
News Archive
The death rates of individual heart surgeons have been published in England and several US states for some years. A high profile investigation into high death rates at a certain cardiac centre motivated this in England. For other surgery types, death rates have been reported only at the hospital or trust level. NHS England's "Everyone Counts" policy, introduced this Summer, means that outcomes of ten types of surgery will be reported at the individual surgeon level.
Tocagen Inc. today announced the publication of data showing the company's investigational treatment for high grade glioma eradicates brain tumors and provides a dramatic survival benefit in mouse models of glioblastoma.
The community of microorganisms that resides in the gut, known as the microbiome, has been shown to work in tandem with the genes of a host organism to regulate insulin secretion, a key variable in the onset of the metabolic disease diabetes.
An enzyme known for its role in heart disease may well be a promising target to treat asthma. Researchers from the University of Iowa have found that the enzyme, called CaMKII, is linked to the harmful effects of oxidation in the respiratory tract, triggering asthmatic symptoms.
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
› Verified 2 days ago
| Entity Name | Renue 012 Essexville Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548740871 PECOS PAC ID: 7618211236 Enrollment ID: O20181207000491 |
News Archive
The death rates of individual heart surgeons have been published in England and several US states for some years. A high profile investigation into high death rates at a certain cardiac centre motivated this in England. For other surgery types, death rates have been reported only at the hospital or trust level. NHS England's "Everyone Counts" policy, introduced this Summer, means that outcomes of ten types of surgery will be reported at the individual surgeon level.
Tocagen Inc. today announced the publication of data showing the company's investigational treatment for high grade glioma eradicates brain tumors and provides a dramatic survival benefit in mouse models of glioblastoma.
The community of microorganisms that resides in the gut, known as the microbiome, has been shown to work in tandem with the genes of a host organism to regulate insulin secretion, a key variable in the onset of the metabolic disease diabetes.
An enzyme known for its role in heart disease may well be a promising target to treat asthma. Researchers from the University of Iowa have found that the enzyme, called CaMKII, is linked to the harmful effects of oxidation in the respiratory tract, triggering asthmatic symptoms.
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gina Grantham, DPT 804 N Water St, Bay City, MI 48708-5620 Ph: (989) 450-3341 | Gina Grantham, DPT 6137 Tittabawassee Rd Ste 3, Saginaw, MI 48603-9696 Ph: (895) 580-9049 |
News Archive
The death rates of individual heart surgeons have been published in England and several US states for some years. A high profile investigation into high death rates at a certain cardiac centre motivated this in England. For other surgery types, death rates have been reported only at the hospital or trust level. NHS England's "Everyone Counts" policy, introduced this Summer, means that outcomes of ten types of surgery will be reported at the individual surgeon level.
Tocagen Inc. today announced the publication of data showing the company's investigational treatment for high grade glioma eradicates brain tumors and provides a dramatic survival benefit in mouse models of glioblastoma.
The community of microorganisms that resides in the gut, known as the microbiome, has been shown to work in tandem with the genes of a host organism to regulate insulin secretion, a key variable in the onset of the metabolic disease diabetes.
An enzyme known for its role in heart disease may well be a promising target to treat asthma. Researchers from the University of Iowa have found that the enzyme, called CaMKII, is linked to the harmful effects of oxidation in the respiratory tract, triggering asthmatic symptoms.
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
› Verified 2 days ago